Dr Greg Moakes
Executive Vice-President of Business Development

About

Greg Moakes is Executive Vice-President of Business Development for LTS Lohmann Device Technologies. Dr Moakes holds a PhD in Chemistry from the Georgia Institute of Technology (Atlanta, GA, US) and an MBA from the Southern Methodist University (Dallas, TX, US). His career had been focused on drug delivery, first specialising in solid-implant dosage formulations and more recently high-volume subcutaneous delivery via on-body delivery systems.

Contributions

WEARABLES

THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS

Mary Lou Glotzbach and Dr Greg Moakes consider the implications of the increasing demand for high-volume injections across the drug delivery industry, and how technologies such as wearable injectors are creating novel challenges for the fill-finish process due to the novel containers involved, making the case that it is only through clear communication and close collaboration between partners that these challenges can be met and surmounted.

More contributions

WEARABLES

TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING

Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.